SCPH: scPharmaceuticals Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 173.42
Enterprise Value ($M) 165.42
Book Value ($M) 37.22
Book Value / Share 1.03
Price / Book 4.66
NCAV ($M) 35.68
NCAV / Share 0.99
Price / NCAV 4.86

Profitability (mra)
Return on Invested Capital (ROIC) -0.71
Return on Assets (ROA) -0.43
Return on Equity (ROE) -0.72

Liquidity (mrq)
Quick Ratio 6.40
Current Ratio 7.08

Balance Sheet (mrq) ($M)
Current Assets 92.94
Assets 94.48
Liabilities 57.26
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 13.59
Operating Income -55.40
Net Income -54.81
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -59.24
Cash from Investing 19.96
Cash from Financing 14.85

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-29 13G Lytton Laurence W 5.10
04-05 13G/A BlackRock Inc. 4.99 -3.32
02-14 13G/A Armistice Capital, Llc 0.00 -100.00
02-14 13G/A 5AM Ventures IV, L.P. 3.30 -56.10
02-12 13G Rubric Capital Management LP 9.76
02-07 13G/A Hirschman Orin 8.70 21.82
02-02 13G/A Cowen Financial Products LLC 0.00 -100.00
01-12 13G/A Millennium Management Llc 1.00 -79.29

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-10 18,186 96,846 18.78
2024-05-09 37,188 59,147 62.87
2024-05-08 47,621 57,539 82.76
2024-05-07 20,826 70,827 29.40
2024-05-06 17,852 32,415 55.07

(click for more detail)

Similar Companies
RVMD – Revolution Medicines, Inc. RXRX – Recursion Pharmaceuticals, Inc.
SANA – Sana Biotechnology, Inc. SDGR – Schrödinger, Inc.
SGMO – Sangamo Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io